German Chancellor Gerhard Schroeder has urged the member companies ofthe International Federation of Pharmaceutical Manufacturers Association to provide affordable treatment for HIV/AIDS patients, especially in Latin America and Africa, a spokesman for the Chancellor has revealed, reports the Associated Press.
The spokesman said a letter from Chancellor Schroeder to IFPMA president Rolf Krebs welcomed Merck & Co's agreement to cut the prices of its AIDS drugs in Brazil (see story opposite), but added that while this was a first step, it was "certainly not" all the German government expected, he said.
A joint statement issued by Chancellor Schroeder and US President George W Bush, after they met in Washington on March 29, said they considered it to be "of particular importance for the pharmaceutical industry to take additional measures so that HIV/AIDS patients in affected developing countries can be supplied with medication at affordable prices."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze